MedTrace Logo

Evaluation of the Effect of the Product RV4660C CY0203 on Clinical, Biometrological and Biological Parameters in Adults With Mild to Moderate Atopic Dermatitis, an Exploratory Study

NCT07166497 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 21

Last updated 2025-09-10

No results posted yet for this study

Summary

In this exploratory study, we assessed the efficacy of a cosmetic product in adults suffering from mild to moderate atopic dermatitis. This exploratory study has been conducted as a monocentric non randomized study.

To perform this clinical study, 21 non menopausal women, aged from 18 years and older, suffering from mild to moderate atopic dermatitis were enrolled.

The subjects applied the investigational product once a day, in the evening on the whole body/ off face for up to 31 days.

4 visits were planned:

* Visit 1 - Day 1 - Inclusion visit
* Visit 2 - Day 8 - Intermediate visit
* Visit 3 - Day 29 (± 3 days) - Intermediate visit
* Visit 4 - Day 36 (± 3 days) - End of study visit

Conditions

  • Mild to Moderate Atopic Dermatitis

Interventions

OTHER

Cosmetic product RV4660C CY0203

The product was applied once a day, in the evening, on the whole body/ off face on previously cleansed skin. The product was warmed in the hands before being applied in wide movements.

Sponsors & Collaborators

  • Pierre Fabre Dermo Cosmetique

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-30
Primary Completion
2023-12-22
Completion
2023-12-22

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07166497 on ClinicalTrials.gov